• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[Comparative effect of administration schedules on the antitumor activities of 3 water-soluble nitrosoureas, ACNU, GANU and MCNU against L1210 leukemia].

作者信息

Kato T, Ota K

出版信息

Gan To Kagaku Ryoho. 1983 May;10(5):1354-62.

PMID:6223585
Abstract

ACNU, GANU and MCNU, water-soluble nitrosoureas, have been evaluated in terms of influence of treatment schedule on antitumor activity in mice bearing L1210 leukemia. The results obtained were as follows: 1) ACNU produced a significant increase in life span and long-term survivors by administration on day 1 only, once every 8 days for 2 doses or once every 4 days for 3 doses, and the compound was most effective when given on day 1 only. 2) GANU produced a significant increase in life span and long-term survivors by same administration schedules as ACNU, and the compound was most effective when given every 8 days for 2 doses. 3) MCNU produced a significant increase in life span and long-term survivors by each administration including daily treatment, and the compound was most effective when given every 4 days for 3 doses. 4) ACNU and MCNU displayed the same level of activity as CCNU when the drugs were given on day 1 only. Daily treatment with MCNU was as effective as daily treatment with CCNU. Our results suggest that ACNU, GANU and MCNU should be administered by intermittent schedule as lipid-soluble nitrosoureas such as BCNU, CCNU and MeCCNU.

摘要

相似文献

1
[Comparative effect of administration schedules on the antitumor activities of 3 water-soluble nitrosoureas, ACNU, GANU and MCNU against L1210 leukemia].
Gan To Kagaku Ryoho. 1983 May;10(5):1354-62.
2
[Experimental studies on oral administration of nitrosourea anti-tumor agent, MCNU].[口服亚硝基脲类抗肿瘤药甲环亚硝脲的实验研究]
Gan To Kagaku Ryoho. 1984 Jul;11(7):1492-500.
3
[Antitumor activity of a new nitrosourea, MCNU, on a cellular morphological basis evaluated by a new in vitro antitumor sensitivity assay].
Gan To Kagaku Ryoho. 1984 Dec;11(12 Pt 1):2550-6.
4
Antitumor activity and toxicity of methyl 6-[3-(2-chloroethyl)- 3-nitrosoureido]-6-deoxy-alpha-D-glucopyranoside in experimental animals.6-[3-(2-氯乙基)-3-亚硝基脲基]-6-脱氧-α-D-吡喃葡萄糖苷甲酯在实验动物中的抗肿瘤活性与毒性
Gan. 1984 Oct;75(10):937-46.
5
Biological and biochemical properties of 1-(2-chloroethyl)-3-(beta-D-glucopyranosyl)-1-nitrosourea (NSC D 254157), a nitrosourea with reduced bone marrow toxicity.
Cancer Res. 1977 Mar;37(3):783-7.
6
A new nitrosourea derivative TA-077, 1-(2-chloroethyl)-3-isobutyl-3-(beta-maltosyl)-1-nitrosourea. I. Comparative study on antitumor activity.一种新的亚硝基脲衍生物TA - 077,1 -(2 - 氯乙基)- 3 - 异丁基 - 3 -(β - 麦芽糖基)- 1 - 亚硝基脲。I. 抗肿瘤活性的比较研究。
Cancer Chemother Pharmacol. 1982;9(3):134-9. doi: 10.1007/BF00257741.
7
Comparison of antitumor activities of nitrosourea derivatives against mammary breast carcinoma (MX-1) in nude mice.亚硝基脲衍生物对裸鼠乳腺腺癌(MX-1)的抗肿瘤活性比较。
Gan. 1980 Oct;71(5):686-91.
8
[Modulation of the antitumor activity of 1-(4-amino-2-methyl-5-pyrimidinyl)methyl-3-(2-chloroethyl)-3-nitrosoure a by O(6)-methyl-2'-deoxyguanosine--a new inhibitor of O(6)-alkylguanine-DNA-alkyltransferase].[O(6)-甲基-2'-脱氧鸟苷对1-(4-氨基-2-甲基-5-嘧啶基)甲基-3-(2-氯乙基)-3-亚硝基脲抗肿瘤活性的调节作用——一种新型O(6)-烷基鸟嘌呤-DNA烷基转移酶抑制剂]
Biokhimiia. 1995 Sep;60(9):1521-9.
9
Biologic activity of MCNU: a new antitumor agent.新型抗肿瘤药物甲环亚硝脲(MCNU)的生物学活性
Cancer Treat Rep. 1979 Jun;63(6):961-70.
10
[Effects of derivatives of Ara-C, 5-fluorouracil and nitrosourea against intracerebral implanted L1210 leukemia].
Gan To Kagaku Ryoho. 1987 Feb;14(2):502-5.